Methodology
Read the full methodology
Weekly index level since May 10, 2026. Constituents are cap-weighted with the divisor reset on each monthly rebalance.
Every atom in the index, cap-weighted with confidence adjustment. Click a row to drill into the underlying card detail. 20 of 24 shown.
| Mew - Unlimited | PSA8 | 21.0% | $1.65M | 93 | 4.1% |
| Mew - Unlimited | PSA9 | 20.1% | $1.58M | 91 | 0.0% |
| Mew - Unlimited | PSA7 | 9.5% | $745.4K | 93 | 0.0% |
| Slowking - Unlimited | PSA9 | 6.6% | $515.3K | 83 | 0.1% |
| Slowking - Unlimited | PSA10 | 6.4% | $505.8K | 59 | 0.0% |
| Slowking - Unlimited | PSA8 | 4.5% | $354.6K | 90 | 0.0% |
| Marill - Unlimited | PSA9 | 3.8% | $297.9K | 78 | 0.7% |
| Marill - Unlimited | PSA10 | 3.6% | $283.2K | 55 | 0.9% |
| Togepi - Unlimited | PSA9 | 3.4% | $270.9K | 78 | 0.2% |
| Togepi - Unlimited | PSA8 | 3.1% | $242.1K | 93 | 0.0% |
| Marill - Unlimited | PSA8 | 2.4% | $185.9K | 88 | 0.0% |
| Mew - Unlimited | PSA10 | 2.2% | $176.1K | 38 | 0.0% |
| Vileplume - Unlimited | PSA10 | 2.2% | $174.3K | 60 | 0.6% |
| Ledyba - Unlimited | PSA10 | 2.1% | $167.9K | 55 | 0.3% |
| Vileplume - Unlimited | PSA9 | 1.7% | $133.0K | 84 | 0.0% |
| Slowking - Unlimited | PSA7 | 1.5% | $120.9K | 82 | 0.0% |
| Togepi - Unlimited | PSA7 | 1.4% | $106.2K | 77 | 9.7% |
| Ledyba - Unlimited | PSA9 | 1.3% | $105.7K | 87 | 0.2% |
| Vileplume - Unlimited | PSA8 | 0.9% | $74.3K | 80 | 0.9% |
| Marill - Unlimited | PSA7 | 0.7% | $54.5K | 86 | 0.0% |
Read the full methodology
Other indices that share this print run or this grade tier, plus the parent set.